Health-related quality of life in patients with newly diagnosed multiple myeloma ineligible for stem cell transplantation: results from the randomized phase III ALCYONE trial

被引：0
|
作者：
Stefan Knop
Maria-Victoria Mateos
Meletios A. Dimopoulos
Kenshi Suzuki
Andrzej Jakubowiak
Chantal Doyen
Paulo Lucio
Zsolt Nagy
Ganna Usenko
Ludek Pour
Mark Cook
Sebastian Grosicki
Andre Crepaldi
Anna Marina Liberati
Philip Campbell
Tatiana Shelekhova
Sung-Soo Yoon
Genadi Losava
Tomoaki Fujisaki
Mamta Garg
Jianping Wang
Susan Wroblewski
Anupa Kudva
Katharine S. Gries
John Fastenau
Jesus San-Miguel
Michele Cavo
机构：
[1] Würzburg University Medical Center,Department of Haematology and Oncology
[2] University Hospital of Salamanca–Instituto de Investigación Biomédica de Salamanca,Department of Internal Medicine
[3] National and Kapodistrian University of Athens,Institute of Hematology, Department of Experimental, Diagnostic and Specialty Medicine
[4] Japanese Red Cross Medical Center,undefined
[5] University of Chicago Medical Center,undefined
[6] Université Catholique of Louvain,undefined
[7] CHU UCL Namur,undefined
[8] Champalimaud Centre for the Unknown,undefined
[9] Semmelweis University,undefined
[10] Dnipropetrovsk City Multidisciplinary Clinical Hospital No. 4,undefined
[11] University Hospital Brno,undefined
[12] University Hospitals Birmingham NHS Trust,undefined
[13] Silesian Medical University,undefined
[14] Clinica de Tratamento E,undefined
[15] Azienda Ospedaliera “Santa Maria”,undefined
[16] Andrew Love Cancer Centre,undefined
[17] Clinic of Professional Pathology,undefined
[18] Seoul National University College of Medicine,undefined
[19] LTD “Medinvent” Institute of Health,undefined
[20] Matsuyama Red Cross Hospital,undefined
[21] Leicester Royal Infirmary,undefined
[22] Janssen Research and Development,undefined
[23] Janssen Research & Development,undefined
[24] LLC,undefined
[25] Clínica Universidad de Navarra–Centro de Investigación Médica Aplicada,undefined
[26] Instituto de Investigación Sanitaria de Navarra,undefined
[27] Centro de Investigación Biomédica en Red de Cáncer,undefined
[28] University of Bologna,undefined
来源：
BMC Cancer | / 21卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Health-related quality of life in transplant ineligible newly diagnosed multiple myeloma patients treated with either thalidomide or lenalidomide-based regimen until progression: a prospective, open-label, multicenter, randomized, phase 3 study
    Nielsen, Lene Kongsgaard
    Stege, Claudia
    Lissenberg-Witte, Birgit
    van der Holt, Bronno
    Mellqvist, Ulf-Henrik
    Salomo, Morten
    Bos, Gerard
    Levin, Mark-David
    Visser-Wisselaar, Heleen
    Hansson, Markus
    van der Velden, Annette
    Deenik, Wendy
    Coenen, Juleon
    Hinge, Maja
    Klein, Saskia
    Tanis, Bea
    Szatkowski, Damian
    Brouwer, Rolf
    Westerman, Matthijs
    Leys, Rineke
    Sinnige, Harm
    Haukas, Einar
    van der Hem, Klaas
    Durian, Marc
    Gimsing, Peter
    van de Donk, Niels
    Sonneveld, Pieter
    Waage, Anders
    Abildgaard, Niels
    Zweegman, Sonja
    HAEMATOLOGICA, 2020, 105 (06) : 1650 - 1659
  • [42] Utilization of Autologous Stem Cell Transplantation in Older Patients with Newly Diagnosed Multiple Myeloma
    King, Justin
    Fiala, Mark A.
    Goldsmith, Scott R.
    Stockerl-Goldstein, Keith E.
    Schroeder, Mark A.
    Ghobadi, Armin
    Vij, Ravi
    Wildes, Tanya M.
    BLOOD, 2019, 134
  • [43] Impact of Response Quality on Survival Outcomes in Transplant-Ineligible Newly Diagnosed Multiple Myeloma (NDMM) Patients (Pts): Results from the First Trial
    Bahlis, Nizar J.
    Corso, Alessandro
    Mugge, Lars-Olof
    Shen, Zhi-Xiang
    Desjardins, Pierre
    Stoppa, Anne-Marie
    Decaux, Olivier
    De Revel, Thierry
    Granell, Miquel
    Marit, Gerald
    Nahi, Hareth
    Demuynck, Hilde
    Huang, Shang-Yi
    Basu, Supratik
    Guthrie, Troy H.
    Ervin-Haynes, Annette
    Leupin, Nicolas
    Marek, Jennifer
    Chen, Guang
    Facon, Thierry
    BLOOD, 2014, 124 (21)
  • [44] Health-Related Quality-of-Life Results From the Open-Label, Randomized, Phase III ASPIRE Trial Evaluating Carfilzomib, Lenalidomide, and Dexamethasone Versus Lenalidomide and Dexamethasone in Patients With Relapsed Multiple Myeloma
    Stewart, A. Keith
    Dimopoulos, Meletios A.
    Masszi, Tamas
    Spicka, Ivan
    Oriol, Albert
    Hajek, Roman
    Rosinol, Laura
    Siegel, David S.
    Niesvizky, Ruben
    Jakubowiak, Andrzej J.
    San-Miguel, Jesus F.
    Ludwig, Heinz
    Buchanan, Jacqui
    Cocks, Kim
    Yang, Xinqun
    Xing, Biao
    Zojwalla, Naseem
    Tonda, Margaret
    Moreau, Philippe
    Palumbo, Antonio
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (32) : 3921 - +
  • [45] Health-related quality of life and quality-adjusted progression free survival for carfilzomib and dexamethasone maintenance following salvage autologous stem-cell transplantation in patients with multiple myeloma: a randomized phase 2 trial by the Nordic Myeloma Study Group
    Nielsen, Lene Kongsgaard
    Schjesvold, Fredrik
    Moeller, Soeren
    Guldbrandsen, Nina
    Hansson, Markus
    Remes, Kari
    Peceliunas, Valdas
    Abildgaard, Niels
    Gregersen, Henrik
    King, Madeleine T.
    JOURNAL OF PATIENT-REPORTED OUTCOMES, 2024, 8 (01)
  • [46] Health-related quality of life and quality-adjusted progression free survival for carfilzomib and dexamethasone maintenance following salvage autologous stem-cell transplantation in patients with multiple myeloma: a randomized phase 2 trial by the Nordic Myeloma Study Group
    Lene Kongsgaard Nielsen
    Fredrik Schjesvold
    Sören Möller
    Nina Guldbrandsen
    Markus Hansson
    Kari Remes
    Valdas Peceliunas
    Niels Abildgaard
    Henrik Gregersen
    Madeleine T. King
    Journal of Patient-Reported Outcomes, 8
  • [47] Health-related quality of life maintained over time in patients with relapsed or refractory multiple myeloma treated with daratumumab in combination with bortezomib and dexamethasone: results from the phase III CASTOR trial
    Hungria, Vania
    Beksac, Meral
    Weisel, Katja C.
    Nooka, Ajay K.
    Masszi, Tamas
    Spicka, Ivan
    Munder, Markus
    Mateos, Maria-Victoria
    Mark, Tomer M.
    Qi, Ming
    Qin, Xiang
    Fastenau, John
    Spencer, Andrew
    Sonneveld, Pieter
    Garvin, Wendy
    Renaud, Thomas
    Gries, Katharine S.
    BRITISH JOURNAL OF HAEMATOLOGY, 2021, 193 (03) : 561 - 569
  • [48] Health-related Quality of Life in Newly Diagnosed Pediatric Patients With Celiac Disease
    Shull, Mary H.
    Ediger, Tracy R.
    Hill, Ivor D.
    Schroedl, Rose L.
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2019, 69 (06): : 690 - 695
  • [49] Health-related quality of life in patients with newly diagnosed type 1 diabetes
    Hart, HE
    Redekop, WK
    Assink, JH
    Meyboom-de Jong, B
    Bilo, HJG
    DIABETES CARE, 2003, 26 (04) : 1319 - 1320
  • [50] Daratumumab plus bortezomib-melphalan-prednisone (VMP) in elderly (≥75 y) patients (Pts) with newly diagnosed multiple myeloma (NDMM) ineligible for transplantation (ALCYONE).
    Cavo, Michele
    Iida, Shinsuke
    Blade, Joan
    Mateos, Maria-Victoria
    Lee, Je-Jung
    Garg, Mamta
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
12345